Montelukast: A Review of Recent Studies in Pediatric Asthma and Allergic Rhinitis
Medscape Montelukast was approved by the Food and Drug Administration (FDA) on February 20, 1998 for the treatment of asthma in children and adults. It has gained widespread acceptance as an adjunct to inhaled corticosteroids and beta-adrenergic agonists in the … |
View full post on asthma – Google News